These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8661721)

  • 41. Cloning and characterization of the Bacillus subtilis hemEHY gene cluster, which encodes protoheme IX biosynthetic enzymes.
    Hansson M; Hederstedt L
    J Bacteriol; 1992 Dec; 174(24):8081-93. PubMed ID: 1459957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isolation and identification of a cDNA clone coding for rat uroporphyrinogen decarboxylase.
    Romeo PH; Dubart A; Grandchamp B; de Verneuil H; Rosa J; Nordmann Y; Goossens M
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3346-50. PubMed ID: 6587353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Haem biosynthesis and human porphyria cutanea tarda: effects of alcohol intake.
    Mukerji SK
    Indian J Exp Biol; 2000 Jul; 38(7):635-42. PubMed ID: 11215304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene.
    Méndez M; Poblete-Gutiérrez P; García-Bravo M; Wiederholt T; Morán-Jiménez MJ; Merk HF; Garrido-Astray MC; Frank J; Fontanellas A; Enríquez de Salamanca R
    Br J Dermatol; 2007 Sep; 157(3):501-7. PubMed ID: 17627795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular analysis of HEM6 (HEM12) in Saccharomyces cerevisiae, the gene for uroporphyrinogen decarboxylase.
    Diflumeri C; Larocque R; Keng T
    Yeast; 1993 Jun; 9(6):613-23. PubMed ID: 8346678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pathogenesis of porphyria cutanea tarda].
    Kószó F; Simon M
    Orv Hetil; 2000 Apr; 141(14):709-13. PubMed ID: 10803012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Familial porphyria cutanea tarda in Spain: characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation.
    Gómez-Abecia S; Morán-Jiménez MJ; Ruiz-Casares E; Henriques-Gil N; García-Pastor I; Garrido-Astray MC; Enríquez de Salamanca R; Méndez M
    Gene; 2013 Jun; 522(1):89-95. PubMed ID: 23545314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase.
    Elder GH; Sheppard DM; De Salamanca RE; Olmos A
    Clin Sci (Lond); 1980 Jun; 58(6):477-84. PubMed ID: 7428280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening for mutations in the uroporphyrinogen decarboxylase gene using denaturing gradient gel electrophoresis. Identification and characterization of six novel mutations associated with familial PCT.
    Christiansen L; Ged C; Hombrados I; Brons-Poulsen J; Fontanellas A; de Verneuil H; Hørder M; Petersen NE
    Hum Mutat; 1999; 14(3):222-32. PubMed ID: 10477430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The first Japanese case of familial porphyria cutanea tarda diagnosed by a UROD mutation.
    Matsui A; Akasaka E; Rokunohe D; Matsuzaki Y; Sawamura D; Nakano H
    J Dermatol Sci; 2019 Jan; 93(1):65-67. PubMed ID: 30522880
    [No Abstract]   [Full Text] [Related]  

  • 51. Isolation and characterization of extragenic mutations affecting the expression of the uroporphyrinogen decarboxylase gene (HEM12) in Sacharomyces cerevisiae.
    Zoładek T; Chełstowska A; Labbe-Bois R; Rytka J
    Mol Gen Genet; 1995 May; 247(4):471-81. PubMed ID: 7770055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uroporphyrinogen decarboxylase in Saccharomyces cerevisiae. HEM12 gene sequence and evidence for two conserved glycines essential for enzymatic activity.
    Garey JR; Labbe-Bois R; Chelstowska A; Rytka J; Harrison L; Kushner J; Labbe P
    Eur J Biochem; 1992 May; 205(3):1011-6. PubMed ID: 1576986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic aspects of porphyria cutanea tarda.
    Lambrecht RW; Thapar M; Bonkovsky HL
    Semin Liver Dis; 2007 Feb; 27(1):99-108. PubMed ID: 17295179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase.
    Phillips JD; Parker TL; Schubert HL; Whitby FG; Hill CP; Kushner JP
    Blood; 2001 Dec; 98(12):3179-85. PubMed ID: 11719352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A point mutation in the coding region of uroporphyrinogen decarboxylase associated with familial porphyria cutanea tarda.
    Garey JR; Hansen JL; Harrison LM; Kennedy JB; Kushner JP
    Blood; 1989 Mar; 73(4):892-5. PubMed ID: 2920211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The molecular basis of porphyria cutanea tarda in Chile: identification and functional characterization of mutations in the uroporphyrinogen decarboxylase gene.
    Poblete-Gutiérrez P; Mendez M; Wiederholt T; Merk HF; Fontanellas A; Wolff C; Frank J
    Exp Dermatol; 2004 Jun; 13(6):372-9. PubMed ID: 15186324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular cloning and nucleotide sequence of a complete human uroporphyrinogen decarboxylase cDNA.
    Roméo PH; Raich N; Dubart A; Beaupain D; Pryor M; Kushner J; Cohen-Solal M; Goossens M
    J Biol Chem; 1986 Jul; 261(21):9825-31. PubMed ID: 3015909
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular defects of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria.
    Meguro K; Fujita H; Ishida N; Akagi R; Kurihara T; Galbraith RA; Kappas A; Zabriskie JB; Toback AC; Harber LC
    J Invest Dermatol; 1994 May; 102(5):681-5. PubMed ID: 8176248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.
    Kushner JP; Barbuto AJ; Lee GR
    J Clin Invest; 1976 Nov; 58(5):1089-97. PubMed ID: 993332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
    Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
    Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.